What is Biohaven's other commercial liabilities?

Biohaven (BHVN) reported other commercial liabilities of $41.65M in Q1 2026.

How has Biohaven's other commercial liabilities changed year-over-year?

Biohaven's other commercial liabilities decreased by 26.4% year-over-year, from $56.57M to $41.65M.

What is the long-term trend for Biohaven's other commercial liabilities?

Over 4 years (2021 to 2025), Biohaven's other commercial liabilities has grown at a 29.4% compound annual growth rate (CAGR), from $37.16M to $104.29M.

Biohaven BHVN Other Commercial Liabilities

Other Commercial Liabilities at other companies

Rapport Therapeutics, Inc.RAPP

——

uniQureQURE

——

Roivant SciencesROIV

——

Vera TherapeuticsVERA

——

AnaptysBio, Inc.ANAB

——

Viridian Therapeutics, Inc.VRDN

——

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Enterprise value$2.26B-46.3%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's other commercial liabilities?: Biohaven (BHVN) reported other commercial liabilities of $41.65M in Q1 2026.
How has Biohaven's other commercial liabilities changed year-over-year?: Biohaven's other commercial liabilities decreased by 26.4% year-over-year, from $56.57M to $41.65M.
What is the long-term trend for Biohaven's other commercial liabilities?: Over 4 years (2021 to 2025), Biohaven's other commercial liabilities has grown at a 29.4% compound annual growth rate (CAGR), from $37.16M to $104.29M.